ADVERTISEMENT

Serum Institute of India

Serum Institute says working to develop mpox vaccine

In India, around 30 mpox cases have been detected since 2022. The most recent case in the country was reported in March 2024.

20 August 2024, 14:19 IST

Serum Institute says working to develop mpox vaccine

Serum Institute says working to develop mpox vaccine

Serum Institute says working to develop mpox vaccine

20 August 2024, 14:19 IST

Covishield side effects: Doctors' group urges govt to review all Covid vaccines

At a press conference, the doctors urged the government to review the science behind all Covid vaccines and audit their commercialisation as well as implementation of active surveillance and monitoring mechanism.

09 May 2024, 16:44 IST

Covishield side effects: Doctors' group urges govt to review all Covid vaccines

Covishield side effects: Doctors' group urges govt to review all Covid vaccines

Covishield side effects: Doctors' group urges govt to review all Covid vaccines

09 May 2024, 16:44 IST

Serum looks beyond Covid with new vaccines for malaria, dengue

The company currently sells about 1.5 billion total vaccine doses every year, and estimates a total production capacity of as much as 4 billion doses.

10 March 2024, 18:48 IST

Serum looks beyond Covid with new vaccines for malaria, dengue

Serum looks beyond Covid with new vaccines for malaria, dengue

Serum looks beyond Covid with new vaccines for malaria, dengue

10 March 2024, 18:48 IST

SII aims to boost supply of cervical cancer shots ahead of government's mass drive

CEO Adar Poonawalla said that he expects the vaccine to be a part of the government's programme by year-end.

04 March 2024, 02:25 IST

SII aims to boost supply of cervical cancer shots ahead of government's mass drive

SII aims to boost supply of cervical cancer shots ahead of government's mass drive

SII aims to boost supply of cervical cancer shots ahead of government's mass drive

04 March 2024, 02:25 IST

Adar Poonawalla to buy London's Most expensive house, Mayfair Mansion

Serum Institute of India CEO Adar Poonawalla will buy Mayfair mansion, in London. Located near Hyde Park, this 25,000 sq ft luxurious mansion has been purchased for a whopping £138 million, the most expensive house to be sold in London in 2023.

12 December 2023, 17:10 IST

Adar Poonawalla to buy London's Most expensive house, Mayfair Mansion

Adar Poonawalla to buy London's Most expensive house, Mayfair Mansion

Adar Poonawalla to buy London's Most expensive house, Mayfair Mansion

12 December 2023, 17:10 IST

World's second malaria vaccine gets WHO approval: Serum Institute of India

The recommendation is based on pre-clinical and clinical trial data which showed good safety and high efficacy in four countries, at sites with both seasonal and perennial malaria transmission, making it the world's second-ever WHO recommended vaccine for preventing malaria in children, SII said in a statement.

03 October 2023, 02:49 IST

World's second malaria vaccine gets WHO approval: Serum Institute of India

World's second malaria vaccine gets WHO approval: Serum Institute of India

World's second malaria vaccine gets WHO approval: Serum Institute of India

03 October 2023, 02:49 IST

SII's BCG vax gets export nod to treat bladder cancer

The product is for intravesical instillation and is available from the Serum Institute in 40 mg and 80 mg presentations.

24 July 2023, 14:20 IST

SII manufactured BCG vaccine gets export nod to treat bladder cancer

SII manufactured BCG vaccine gets export nod to treat bladder cancer

SII's BCG vax gets export nod to treat bladder cancer

24 July 2023, 14:20 IST

Centre waives testing need for SII's Cy-Tb injection

The move comes after Prakash Kumar Singh, Director, Serum Institute of India wrote to the Union health ministry

18 June 2023, 16:38 IST

Centre waives testing requirement for SII's Cy-Tb injection at govt labs

Centre waives testing requirement for SII's Cy-Tb injection at govt labs

Centre waives testing need for SII's Cy-Tb injection

18 June 2023, 16:38 IST

SII to double investment in Biocon's unit to $300 mn

Serum Institute of Life Sciences had already invested $150 million in Biocon Biologics in November 2022

26 April 2023, 01:10 IST

Serum subsidiary doubles investment in Biocon unit to $300 million

Serum subsidiary doubles investment in Biocon unit to $300 million

SII to double investment in Biocon's unit to $300 mn

26 April 2023, 01:10 IST

Oxford, SII tie-up delivers 'high efficacy' malaria vax

The R21/Matrix-M vaccine, leveraging Novavax’s adjuvant technology, has been approved for use in children aged 5 to 36 months

13 April 2023, 13:09 IST

Oxford University, Serum Institute of India tie-up delivers 'high efficacy' malaria vaccine

Oxford University, Serum Institute of India tie-up delivers 'high efficacy' malaria vaccine

Oxford, SII tie-up delivers 'high efficacy' malaria vax

13 April 2023, 13:09 IST